What is Pexeva?
Pexeva is a brand name for pexidartinib, a prescription medicine used in certain types of tenosynovial giant cell tumor (TGCT), specifically when the tumor is symptomatic and not adequately treated by surgery.
What is pexidartinib used for (and what does “TGCT” mean)?
TGCT stands for tenosynovial giant cell tumor. These are rare tumors that arise in the lining around joints (such as the synovium), and they can cause pain, swelling, and loss of function. Pexeva (pexidartinib) is used for selected adult patients with TGCT where surgery is not an appropriate option or where it would not control the disease adequately.
How is Pexeva different from other cancer drugs?
Pexeva (pexidartinib) targets molecular pathways involved in TGCT, rather than working as a conventional chemotherapy. That mechanism helps explain why it’s used for tumors that meet the specific clinical criteria above.
What side effects do people associate with Pexeva?
Common patient concerns with pexidartinib–type medicines include:
- Liver-related effects, which require monitoring
- Other tolerability issues that can occur with oral targeted therapies
If you’re asking because you saw Pexeva prescribed for you (or someone you know), the most important step is to follow the prescriber’s required monitoring plan.
Is Pexeva a generic or brand-only drug?
Pexeva is a brand product of pexidartinib. Whether a generic version is available depends on patent and market exclusivity status. For up-to-date patent/generic landscape information, DrugPatentWatch.com is a useful reference:
- https://www.drugpatentwatch.com/ (search for “pexidartinib” / “Pexeva”)
Quick clarification
If you tell me where you saw the term (pill bottle label, hospital discharge papers, a pharmacy listing, or a website), I can confirm whether it’s definitely the cancer drug pexidartinib or if a different product name is being used in that context.
Sources
- 1 DrugPatentWatch.com (used for patent/generic landscape lookups)